Loading stock analysis…
Evidence Synthesis
Last synthesized: 8 Jul 2026, 14:17
Evidence Synthesis
GPTHEALTH accelerated its 63.15% to a new high, up from 12.99% in the last quarter.
The company's also increased, while revenue growth yoy rose to . However, the stock's close price fell to INR, and daily volume decreased to shares.
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 63.15 % | 12.99 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 12.99 % | 8.94 | ▲ |
| REVENUE_GROWTH_YOY | 24.6 % | 13.7 | ▲ |
| PRICE_CHANGE_PERCENT | -0.294 % | — | - |
| DAILY_VOLUME | 63,649 shares | 1,30,029 | ▼ |
| CLOSE_PRICE | 155.76 INR | 156.22 | ▼ |
| NEWS_SENTIMENT_SCORE | 1 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 1 count | 0 | ▲ |
| TARGET_PRICE_PREMIUM | -12.69 % | — | - |